UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | C000000404 |
|---|---|
| Receipt number | R000000493 |
| Scientific Title | Phase I and IIa, Dose Escalation, Non-Randomized, Safety and Efficacy Evaluation Clinical Study for Angiogenic Gene Therapy to Treat Patients with Critical Limb Ischemia via Intramuscular Injection of Non-Transmissible Recombinant Sendai Virus Expressing Human Fibroblast Growth Factor-2 (FGF-2) Gene. |
| Date of disclosure of the study information | 2006/04/20 |
| Last modified on | 2013/04/24 03:15:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2006/04/12 17:18:24 | ||
| 2 | Update | 2009/10/13 10:20:16 | Last name of contact person Last name of contact person Homepage URL Name of person sending information Name of person sending information Organization Division name Address Organization1 Institutions |
|
| 3 | Update | 2013/04/24 03:15:01 | Recruitment status Publication of results Results Results Other related information Other related information |
